doi:

DOI: 10.3724/SP.J.1123.2018.11046

Chinese Journal of Chromatography (色谱) 2019/37:4 PP.412-417

Reversed-phase liquid chromatography separation and mass spectrometry fragmentation analysis of mitiglinide and three isomers


Abstract:
The separation of mitiglinide and its three isomer impurities was achieved by reversed-phase ultra-performance liquid chromatography-high resolution mass spectrometry. An ACQUITY UPLC HSS T3 column (100 mm×2.1 mm, 1.8 μm) was used as the stationary phase and water-acetonitrile-n-pentanol (75:25:1, v/v/v; formic acid was added to adjust pH to 1.8) was used as the mobile phase with a flow rate of 0.4 mL/min. According to the exact mass and high resolution mass spectrometry fragmentation (Q Exactive), significant differences were observed in the fragment ion abundance in the secondary mass spectra of mitiglinide and its three isomer impurities. Two of these isomer impurities were newly discovered. The possible fragmentation mechanisms of mitiglinide and its three isomer impurities were also deduced. The limit of detection of the developed method was 1 μg/L. The linearity of the developed method was good from the limit of quantitation (2 μg/L) to 10000 μg/L with a correlation coefficient of 0.9999. The relative standard deviation of the peak area was 2.0%. On the basis of these results, the sources of the mitiglinide isomer impurities were discussed. Isomer impurity 1 was degraded at high temperature, while isomer impurities 2 and 3 were determined to be synthetic impurities. In addition, samples of mitiglinide calcium raw materials were analyzed.

Key words:reversed-phase liquid chromatography (RPLC),mass spectrometry (MS),mitiglinide,isomers,fragmentation mechanism

ReleaseDate:2019-04-12 10:34:08



[1] Ohnota H, Koizumi T, Tsutsumi N, et al. J Pharmaco Exp Ther, 1994, 269(2):489

[2] Kaiser N, Nesher R, Oprescu A, et al. Br J Pharmacol, 2005, 146(6):872

[3] Chen X. Strait Pharmaceutical Journal, 2018, 30(8):68 陈晓. 海峡药学, 2018, 30(8):68

[4] Liu S J, Huang G D, Sun B T, et al. Chinese Journal of Clinical Pharmacy, 2017, 26(1):10 刘史佳, 黄国栋, 孙冰婷, 等. 中国临床药学杂志, 2017, 26(1):10

[5] Zeng T, Huo D Q, Zhou X M, et al. China Pharmaceuticals, 2013, 22(17):28 曾檀, 霍丹群, 周祥敏, 等. 中国药业, 2013, 22(17):28

[6] Mao Z Y, Zhang F C, Liu H Q. Chinese Journal of Pharmaceuticals, 2007, 38(9):650 毛志英, 张发成, 刘汉清. 中国医药工业杂志, 2007, 38(9):650

[7] Zhang X L, Ling Y P, Luo Y Q, et al. China Pharmacy, 2016, 27(1):64 张晓丽, 凌益平, 骆雅琴, 等. 中国药房, 2016, 27(1):64

[8] Zhang J, Cai L J, Peng W X, et al. J Clin Pharm Ther, 2012, 37:95

[9] Liu Y T, Zhang X F, Yang C C. Pharmaceutical Journal of Chinese People's Liberation Army, 2017, 33(1):53 刘雅婷, 张行飞, 杨常成. 解放军药学学报, 2017, 33(1):53

[10] Zhang Y, Ding L, Tian Y, et al. Biomed Chromatogr, 2008, 22:873

[11] Hadi H, Makahleh A, Saad B, et al. J Chromatogr B, 2012, 895/896:131

[12] Xing Y R, Zhao G M, Liu Y. Chinese Journal of Pharmaceutical Analysis, 2006, 26(7):1017 邢玉仁, 赵国敏, 刘燕. 药物分析杂志, 2006, 26(7):1017

[13] Zhang Z F, Yang G L, Gao W H, et al. Chin J Chem, 2009, 27(1):29

[14] Zheng Y B, Huang B F, Ren Y P. Chinese Journal of Chromatography, 2016, 34(7):692 郑熠斌, 黄百芬, 任一平. 色谱, 2016, 34(7):692

[15] Xu J H, Xue Y, Wang Y, et al. Chemistry and Bioengineering, 2017, 34(6):65 徐静涵, 薛芸, 王彦, 等. 化学与生物工程, 2017, 34(6):65

[16] Zheng Y B, Pan X D, Xu J J, et al. Chinese Journal of Food Hygiene, 2017, 29(6):698 郑熠斌, 潘晓东, 许娇娇, 等. 中国食品卫生杂志, 2017, 29(6):698

[17] Wang D W, Wang X N, Feng M J, et al, Journal of Instrumental Analysis, 2014, 33(10):1123 王东武, 王西宁, 丰梅君, 等. 分析测试学报, 2014, 33(10):1123

[18] Liu C Y, Zou X J. Police Technology, 2016(6):87 刘传银, 邹小建. 警察技术, 2016(6):87

[19] Yao B X, Yang X M, Zheng H M, et al. China Reagent, 2014, 36(6):560 姚碧霞, 杨新梅, 郑慧敏, 等. 化学试剂, 2014, 36(6):560

[20] Yang G X, Chen X Q, Huang J, et al. Chinese Journal of Antibiotics, 2015, 50(2):91 杨国新, 陈夏琴, 黄婕, 等. 中国抗生素杂志, 2015, 50(2):91

[21] Sastry T U, Rao K N, Reddy T A, et al. Asian J Chem, 2014, 26(8):2417

[22] Zhou X L. Contemporary Medicine Forum, 2014, 12(7):3 周晓兰. 当代医药论丛, 2014, 12(7):3